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Tomonori Sato1, Yoshiaki Ito2* and Takashi Nagasawa2Abstract
The prevention of muscle wasting is important for maintaining quality of life, since loss of muscle mass can lead to
a bedridden state and decreased resistance to diseases. The prevention of muscle wasting requires an increase in
protein synthesis and a decrease in protein degradation in skeletal muscle. We previously showed that lysine (Lys)
markedly suppressed myofibrillar protein degradation by inhibiting the autophagic-lysosomal system via the
mammalian target of rapamycin (mTOR) and other signal molecules in C2C12 cells. In this study, we investigated
the involvement of Akt and adenosine 5′-monophosphate (AMP)-activated protein kinase (AMPK), two regulators
of autophagy, on the suppressive effects of Lys on myofibrillar protein degradation in C2C12 cells. Lys induced
the phosphorylation of Akt, but the suppressive effects of Lys on myofibrillar protein degradation and autophagy
were completely abolished in the presence of Akt1/2 kinase inhibitor (Akti). Lys suppressed the phosphorylation
of AMPK, but this effect was also abolished by Akti. On the other hand, AMPK activation by 5-aminoimidazole-4-carbox-
amide-1-β-D-ribonucleoside (AICAR) did not affect either Akt activity or the autophagic-lysosomal system in C2C12 cells
treated with Lys. These results indicate that regulation of AMPK activity is not essential for the regulation of autophagy
by Lys. Taken together, our results show that Lys suppresses myofibrillar protein degradation by the autophagic-lysosomal
system through the phosphorylation of Akt in C2C12 cells.
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Skeletal muscle mass reduction is induced when the
rate of protein degradation exceeds the rate of protein
synthesis in skeletal muscle (Welle 1999). Such changes are
caused by several catabolic diseases and by underutilization
or disuse of muscle, and lead to muscle wasting (Vary and
Lynch 2004; Wolfe 2006; Tisdale 2009). Muscle wasting in
turn leads to decreased physical activity and ultimately to a
bedridden state. Although appropriate exercise enhances
protein synthesis (Mascher et al. 2007; Koopman and van
Loon 2009), it is difficult for severely ill patients or the eld-
erly to exercise sufficiently to stimulate protein synthesis. In
addition, the cellular and molecular responses to exercise
leading to enhanced protein synthesis are decreased in the
elderly (Kim et al. 2009). Therefore, a less physically* Correspondence: yito@iwate-u.ac.jp
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in any medium, provided the original work is pstraining means7 of preventing muscle wasting is required
for the elderly, infirm, and persons with disabilities. The
most effective approach for these patients is to improve
their nutritional state.
Leucine (Leu), one of the essential amino acids, has
been reported to stimulate protein synthesis (Kimball
et al. 1999; Lang et al. 2012) and to attenuate protein
degradation (Nagasawa et al. 2002; Sugawara et al.
2007). We previously showed that dietary intake of Leu
suppresses myofibrillar protein degradation through the
autophagic-lysosomal system (Sugawara et al. 2009). Fur-
thermore, we also demonstrated that orally administered
Lys suppresses myofibrillar protein degradation in fasted
rats (Sato et al. 2013), and that the suppressive effect of
Lys on myofibrillar protein degradation is mediated by
the autophagic-lysosomal system in C2C12 myotubes
(Sato et al. 2014). In a previous study, we established
that the mTOR pathway is involved in the suppressive
effect of Lys on the autophagic-lysosomal systemOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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be mediated through a signal molecule other than mTOR
because the contribution of the mTOR pathway is limited.
We observed the activation of Akt in C2C12 cells treated
with Lys (Sato et al. 2014). Akt is reported to regulate pro-
tein degradation through the autophagic-lysosomal system
(Arico et al. 2001; Mammucari et al. 2008). AMPK is also
known to regulate autophagic-lysosomal activity (Sanchez
et al. 2012). In addition, it has been reported that Akt activ-
ity negatively regulates phosphorylation of AMPK (Kovacic
et al. 2003). Although Akt phosphorylation is induced
by Lys, the involvement of Akt phosphorylation on the
regulation of myofibrillar protein degradation and on
AMPK activity remains unclear.
In this study, we investigated whether Lys suppresses
myofibrillar protein degradation through regulation of
the Akt and/or AMPK pathway in C2C12 cells.
Materials and methods
Materials
Fetal bovine serum (FBS) and horse serum (HS) were
purchased from BioWest (Nuaillé, France) and Invitro-
gen (Carlsbad, CA, USA), respectively. Dulbecco’s
modified Eagle’s medium (DMEM, low glucose), mini-
mum essential medium (MEM) Vitamin mix, Akti
and dimethyl sulfoxide (DMSO) were obtained from
Sigma (St. Louis, MO, USA). HEPES was obtained from
Dojindo Molecular Technologies, Inc. (Kumamoto, Japan).
LC3B antibody, AMPKα rabbit mAb, phospho-AMPKα
(Thr172) rabbit mAb and AICAR were obtained from Cell
Signaling Technology, Inc. (Danvers, MA, USA). 4E-BP1
(R-113), Akt1 (B-1) and p-Akt 1/2/3 (Ser 473) were ob-
tained from Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA, USA). HRP-conjugated goat anti-rabbit IgG and
HRP-conjugated goat anti-mouse IgG were obtained from
Kirkegaard & Perry Laboratories, Inc. (Gaithersburg, MD,
USA). Other chemicals were obtained from Wako Pure
Chemical Industries Ltd. (Osaka, Japan).
Cell culture
C2C12 myoblasts (5.0 × 104 cells/cm2) were seeded into
DMEM containing antibiotics (100 units/mL penicillin
and 100 μg/mL streptomycin), 10% (v/v) FBS and 44 mM
sodium bicarbonate, and then cultured for 2 days. Fusion
and differentiation of myoblasts into myotubes were in-
duced by replacing the medium containing 10% FBS with
medium containing 2% (v/v) HS. Fusion and differenti-
ation conditions were maintained for 6 days, during which
the medium was changed daily.
Measurement of myofibrillar protein degradation
Since 3-methylhistidine (MeHis) is primarily in myosin
and actin, two myofibrillar proteins and is not reused for
protein synthesis (Young and Munro 1978), the rate ofMeHis release from muscle cells directly reflects the rate
of myofibrillar protein degradation (Sato et al. 2014). We
measured the rates of MeHis release from C2C12 as de-
scribed previously (Sato et al. 2014). In brief, myotube
cells were rinsed twice with phosphate buffered saline
(PBS) after 6 days of differentiation. Then, the cells were
cultured for 4 h in serum and amino acid (AA)-deficient
medium ((C): [1 mg ferric nitrate・9H2O/L, 0.4 g KCl/L,
6.4 g NaCl/L, 0.142 g NaH2PO4・2H2O/L, 1.0 g glucose/L,
0.265 g CaCl2・2H2O/L, 0.2 g MgSO4・7H2O/L, 0.1%
(w/v) bovine serum albumin (BSA), 1% (v/v) MEM
Vitamin mix, 20 mM HEPES and antibiotics]), serum
and AA-deficient medium containing 10 μM Akti (Ai),
serum and AA-deficient medium containing 10 mM
Lys (K), serum and AA-deficient medium containing
10 mM Lys and 10 μM Akti (AiK), serum and AA-
deficient medium containing 1 mM AICAR (Ac), or
serum and AA-deficient medium containing 10 mM
Lys and 1 mM AICAR (AcK). The rate of myofibrillar
protein degradation was measured during the 4 h cul-
ture period.
Western blot analysis
After 6 days of differentiation, the myotube cells were
rinsed twice with PBS and incubated with DMEM con-
taining 0.1% (w/v) BSA for 6 h. Then, the medium was
replaced with new DMEM containing 0.1% (w/v) BSA,
DMEM containing 0.1% (w/v) BSA and 10 mM
Leu, DMEM containing 0.1% (w/v) BSA and 10 mM
Lys, or DMEM containing 0.1% (w/v) BSA and 10 mM
Gly. Akti (10 μM) or AICAR (1 mM) dissolved in
DMSO (final concentration of 0.05% (v/v)) or DMSO
alone (final concentration of 0.05% (v/v)) was added to
the medium 30 min before amino acid stimulation. Myo-
tubes in DMEM containing 0.1% (w/v) BSA with 10 mM
Leu (L), 10 mM Lys (K), 10 mM Gly (G), or without
amino acids supplementation (C) were cultured for
30 min, treated with lysis buffer solution (1% (v/v) Triton-
X, 5% (w/v) deoxycholic acid, 0.1% (v/w) sodium dodecyl
sulfate (SDS), 20 mM Tris–HCl (pH 7.4), 150 mM sodium
chloride, 0.5 mM sodium orthovanadate (V) and 5 mM
EDTA), then collected. Collected myotubes were centri-
fuged at 4°C, 17,900 × g for 10 min, then the supernatant
was subjected to SDS-PAGE. Equal amounts of protein
from each of the samples were separated on 10%
SDS-PAGE gels, then transferred to a PVDF membrane
(Millipore Corporation, Billerica, MA, USA). The mem-
brane was blocked for 1 h with 5% skim milk in Tris
buffered saline (TBS) containing 0.1% Tween 20 (TBS-T)
at room temperature. The membrane was incubated over-
night at 4°C with primary antibodies, then the membrane
was incubated with HRP-conjugated goat anti-rabbit IgG
or HRP-conjugated goat anti-mouse IgG in TBS-T. The
secondary antibody was detected using an ECL western
Sato et al. SpringerPlus 2014, 3:584 Page 3 of 12
http://www.springerplus.com/content/3/1/584blot detection kit (GE Healthcare, Tokyo, Japan). The bands
were scanned using a luminescent image analyzer
(ImageQuant LAS 4000, GE Healthcare) and the relative
intensity of each band was estimated using NIH Image.
Gene expression of ubiquitin-ligase
The myotube cells were rinsed twice with PBS after
6 days of differentiation, then cultured in serum and
AA-deficient medium for 1 h. Then, the cells were incu-
bated in serum and AA-deficient medium (C) containing
either 1 mM AICAR (Ac), 10 mM Lys (K), or 10 mM
Lys and 1 mM AICAR (AcK), for 30 min or 4 h. Subse-
quently, the mRNA expressions of E3 ubiquitin ligases,
muscle ring-finger protein 1 (MuRF1) and atrogin-1
were measured. Total RNA was extracted from the
treated cells at the indicated time. Ten micrograms of
total RNA from each C2C12 culture were separated on a
1.2% agarose-formaldehyde gel and transferred to a
positively-charged nylon membrane (Pall Corporation,
Port Washington, NY, USA). After UV cross-linking,
membranes were hybridized with a digoxigenin-labeled
cDNA probe specific to MuRF1, atrogin-1 or GAPDH
for 12 to 16 h at 50°C in hybridization solution (5× SSC,
50% formamide, 50 mM sodium phosphate buffer, pH 7.0,
7% SDS, 2% blocking reagent (Roche Diagnostics,
Mannheim, Germany), and 0.1% N-lauroylsarcosine).
Membranes were washed twice with 2× SSC-0.1% SDS
for 15 min at room temperature and twice with 0.1× SSC-
0.1% SDS for 15 min at 68°C. Specific hybridization was
detected with an anti-digoxigenin antibody conjugated
with alkaline phosphatase, and blots were developed with
CDP-star reagent (Tropix, Bedford, MA, USA). The bands
were scanned using a luminescence image analyzer (Ima-
geQuant LAS 4000) and the relative intensity of each band
was estimated using NIH Image.
Statistical analysis
Data are expressed as mean with SE. Data analysis was
performed using GraphPad Instat Software version 3.0a
(2001, GraphPad Software, Inc., San Diego, CA, USA).
Data were analyzed by analysis of variance (ANOVA)
and Tukey’s post-test in multigroup comparisons to
determine whether there were significant differences
(p < 0.05) among the groups.
Results
Activation of the Akt pathway by Lys suppresses
myofibrillar protein degradation through regulation of
the autophagic-lysosomal system
The phosphorylation levels of Akt Ser473 and Thr308
were significantly increased upon stimulation with
10 mM Leu (L) or 10 mM Lys (K), and these up-
regulations of Akt phosphorylation were abolished by
Akti (Figure 1).To investigate whether the suppressive effect of Lys on
myofibrillar protein degradation depends on the acti-
vation of Akt, we measured the rate of myofibrillar
protein degradation in C2C12 myotubes treated with
10 mM Lys and 10 μM Akti. Lys did not suppress myo-
fibrillar protein degradation when Akt activity was
inhibited by Akti (AiK), whereas treatment with Lys
alone (K) markedly suppressed myofibrillar protein
degradation (Figure 2).
Light chain 3 (LC3) is a mammalian homolog of
Apg8p, a protein that is essential for the autophagic-
lysosomal system in yeast. LC3 has two forms: LC3-I
and LC3-II. The ratio of LC3-II to total LC3 (LC3-I +
LC3-II) was used as a marker of autophagy (Naito et al.
2013). We evaluated the involvement of Akt activation
induced by Lys in the regulation of autophagic-lysosomal
activity by the ratio of LC3-II to total LC3. The ratio of
LC3-II to total LC3 was reduced in C2C12 cells treated
with Lys (K), however, this reduction was abolished by
treatment with Akt inhibitor (AiK). Similar results
were observed when the cells were treated with Leu
(Figure 3). These results suggest that the suppression
of the autophagic-lysosomal system by Lys is dependent
on the activation of Akt.
Lys regulates the mTOR and AMPK pathways through
activation of Akt
Next, we investigated the effect of Akt activation by Leu
and Lys on the mTOR and AMPK pathways. One down-
stream target of mTOR, eIF4E-binding protein 1 (4E-BP1),
was significantly phosphorylated by treatment with Leu (L)
or Lys (K), and the up-regulation of 4E-BP1 phosphoryl-
ation was abolished by Akti (AiK) (Figure 4a). The level of
AMPK phosphorylation was suppressed by 40% when the
medium was supplemented with Leu or Lys, and the sup-
pressive effect of Lys on AMPK phosphorylation was abol-
ished by Akti (Figure 4b). These results indicated that Lys
regulates the mTOR and AMPK pathways through Akt
activation.
Akt plays a dominant role in the regulation of
autophagic-lysosomal activity compared to the AMPK
pathway
We addressed the physiological role of the regulation of
AMPK activity by Akt. To do this, we examined three
effects of AICAR: on the phosphorylation of Akt, on
autophagic-lysosomal activity, and on MeHis release
upon Lys treatment. It was previously reported that the
AMPK pathway induces myofibrillar protein degradation
(Nakashima and Yakabe 2007). We found that AICAR
treatment induced AMPK activation, and that this
activation was not suppressed by Leu or Lys treatment
(Figure 5a). Activation of Akt by Leu or Lys was also not
affected by AICAR treatment (Figure 5b). The ratio of
Figure 1 Lys induces phosphorylation of Akt in C2C12 myotubes. C2C12 myotubes were treated for 30 min with DMSO (C), 10 μM Akti (Ai),
10 mM Leu (L), 10 mM Leu and 10 μM Akti (AiL), 10 mM Lys (K), or 10 mM Lys and 10 μM Akti (AiK). The phosphorylation level of Akt Ser473
(a) and Akt Thr308 (b) in the lysates was analyzed by Western blotting. Results are expressed as the level relative to the expression level of the
control group. Representative immunoblots are shown. Values are means with SE (n = 3–4). Different letters indicate significant differences among
the groups (p < 0.05).
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ment, but the ratio decreased when Leu or Lys was
added to the medium, even in the presence of AICAR
(Figure 5d). These results suggested that Akt, rather than
AMPK pathway, might dominantly regulate autophagic-
lysosomal activity.
The mTOR pathway is suppressed by the AMPK pathway
(Bolster et al. 2002), and the mTOR pathway is involved
in the suppressive effect of Lys on autophagic-lysosomal
activity (Sato et al. 2014). Consequently, we investigatedwhether mTOR activity is affected by AMPK activation.
Activation of the AMPK pathway by AICAR decreased
the basal phosphorylation level of 4E-BP1 and reduced the
phosphorylation levels of 4E-BP1 induced by Leu or Lys
(Figure 5c). These results suggest that mTOR activity may
not be critical for the regulation of autophagic-lysosomal
activity by Lys.
MeHis release is an index of myofibrillar protein deg-
radation. MeHis release increased in the presence of
AICAR and Lys compared to in the presence of Lys
Figure 2 Lys suppresses myofibrillar protein degradation through activation of Akt in C2C12 myotubes. Cells were incubated in medium
containing DMSO (C), 10 μM Akti (Ai), 10 mM Lys (K), or 10 mM Lys with 10 μM Akti (AiK) for 4 h. The amount of MeHis released from the cells
was measured by HPLC. Values are means with SE (n = 3). Different letters indicate significant differences among the groups (p < 0.05).
Figure 3 Lys suppresses the autophagic-lysosomal system through activation of Akt in C2C12 myotubes. Cells were treated for 30 min
with DMSO (C), 10 μM Akti (Ai), 10 mM Leu (L), 10 mM Leu and 10 μM Akti (AiL), 10 mM Lys (K), or 10 mM Lys and 10 μM Akti (AiK). The ratio of
LC3-II to total LC3 (LC3-I + LC3-II) in the lysates was determined by Western blotting. Results are expressed as the level relative to the control
group. Values are means with SE (n = 3–4). Different letters indicate significant differences among the groups (p < 0.05).
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Figure 4 Lys regulates the mTOR and AMPK pathways by activating Akt in C2C12 myotubes. Cells were treated for 30 min with DMSO (C),
10 μM Akti (Ai), 10 mM Leu (L), 10 mM Leu and 10 μM Akti (AiL), 10 mM Lys (K), or 10 mM Lys and 10 μM Akti (AiK). The phosphorylation level of
4E-BP1 (a) and AMPK (b) in the lysates was analyzed by Western blotting. The level of 4E-BP1 phosphorylation was estimated from the ratio of
the γ-form to that of total 4E-BP1. Results are expressed as the level relative to the level in the control group. Representative immunoblots are
shown. Values are means with SE (n = 3–4). Different letters indicate significant differences among the groups (p < 0.05).
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lysosomal activity (the ratio of LC3-II to total LC3)
was sufficiently suppressed by Lys in the presence of
AICAR (Figure 5d). AICAR treatment was reported to
induce the expression of the E3 ubiquitin ligase genes,
MuRF1 and atrogin-1, in C2C12 myotubes (Nakashima
and Yakabe 2007); therefore, we examined whether AICAR
treatment stimulates the ubiquitin-proteasomal system.
The expression of MuRF1 and atrogin-1 mRNA signifi-
cantly increased in C2C12 cells treated with Lys and
AICAR (AcK), whereas treatment with either AICAR or
Lys alone (Ac, K) did not affect MuRF1 and atrogin-1
mRNA levels (Figure 7). Therefore, the increase in MeHisrelease may reflect activation of the ubiquitin-proteasomal
system in cells treated with Lys and AICAR.
Glycine slightly induces Akt activation and does not
regulate the phosphorylation of AMPK and the
autophagic-lysosomal system
We previously showed that Gly does not suppress myofi-
brillar protein degradation in C2C12 myotubes (Sato
et al. 2014). However, it is still unknown whether Gly
regulates the activities of autophagy and signal mole-
cules which regulate autophagy. We therefore investi-
gated the effect of Gly on the phosphorylation levels of
Akt and AMPK, and on the activity of the autophagic-
Figure 5 Effect of Lys and/or AICAR treatment on activation of the AMPK, Akt and mTOR pathways, and on the autophagic-lysosomal
system in C2C12 myotubes. Cells were treated with DMSO (C), 1 mM AICAR (Ac), 10 mM Leu (L), 10 mM Leu and 1 mM AICAR (AcL), 10 mM
Lys (K), or 10 mM Lys and 1 mM AICAR (AcK) for 30 min. The lysates were analyzed for phosphorylation levels of AMPK (a), Akt (b) and 4E-BP1 (c),
and the ratio of LC3-II to total LC3 (LC3-I + LC3-II) (d), by Western blotting. Results are expressed as the level relative to the control group. Values
are means with SE (n = 3–4). Different letters indicate significant differences among the groups (p < 0.05).
Sato et al. SpringerPlus 2014, 3:584 Page 7 of 12
http://www.springerplus.com/content/3/1/584lysosomal system in C2C12 myotubes. The phosphoryl-
ation level of Akt Ser473 slightly increased upon Gly
treatment, but the level was much lower than that ob-
tained following Lys stimulation. In addition, the phos-
phorylation level of Akt Thr308 did not increase upon
Gly treatment (Figure 8a, b). Furthermore, Gly did not
affect the phosphorylation of AMPK (Figure 8c), and the
ratio of LC3-II to total LC3 was not changed by Gly
treatment (Figure 8d). These results demonstrate that
regulation of the Akt and AMPK pathways, and of the
autophagic-lysosomal system, is specific to Lys, and thatthe effect of Lys is not merely due to it being a supple-
mental nitrogen source.
Discussion
Leu is known to activate mTOR signaling, which stimu-
lates muscle protein synthesis and suppresses protein
degradation (Kimball et al. 1999; Kim et al. 2009). We
previously showed that Lys suppresses myofibrillar pro-
tein degradation through mTOR signaling and another
signaling pathway, and we observed significant up-
regulation of Akt phosphorylation by Lys (Sato et al. 2014).
Figure 6 Effect of Lys and/or AICAR treatment on myofibrillar protein degradation in C2C12 myotubes. Cells were incubated in medium
containing DMSO (C), 1 mM AICAR (Ac), 10 mM Lys (K), or 10 mM Lys and 1 mM AICAR (AcK) for 4 h. MeHis released from the cells was
measured by HPLC. Values are means with SE (n = 3). Different letters indicate significant differences among the groups (p < 0.05).
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system (Arico et al. 2001; Mammucari et al. 2008).
Therefore, we here investigated whether Lys suppresses
myofibrillar protein degradation by regulating the phos-
phorylation of Akt in C2C12 myotubes.
The phosphorylation level of Akt Ser473 significantly
increased with Lys treatment (Figure 1a), as shown pre-
viously (Sato et al. 2014), and the phosphorylation level
of Akt Thr308 also significantly increased in the pres-
ence of Lys (Figure 1b). The suppressive effect of Lys on
myofibrillar protein degradation was completely abol-
ished when Akt phosphorylation was inhibited by Akti
(Figures 1 and 2). These results clearly demonstrate that
Lys suppresses myofibrillar protein degradation by acti-
vating Akt. Similarly, the autophagic-lysosomal system
in C2C12 cells treated with Akti was not suppressed by
Lys, since the ratio of LC3-II to total LC3 did not de-
crease (Figure 3). This result indicates that activation of
Akt is essential for the suppression of the autophagic-
lysosomal system by Lys.
Several studies have shown that Akt is activated by the
addition of amino acids. Tato et al. (2011) showed that
Akt is phosphorylated following the addition of a mix-
ture of amino acids, and Leu has been reported to acti-
vate Akt phosphorylation (Lee et al. 2008; Coëffier et al.
2011; Zeanandin et al. 2012). These studies support our
finding that Lys is another stimulating amino acid that
can activate the Akt pathway (Figure 1). However, the ef-
fect on Akt activation seems to be specific to certainamino acids, as Gly only slightly stimulated Akt phos-
phorylation and did not suppress autophagic-lysosomal
activity (Figure 8). Therefore, Lys may be an important
regulatory amino acid in muscle protein metabolism.
It has been reported that Akt suppresses autophagy via
mTOR signaling (Janku et al. 2011; Jamart et al. 2012;
Seldin et al. 2013). In this study, we found that activation
of Akt by Lys regulates mTOR signaling (Figure 4a).
However, we previously showed that mTOR signaling
plays a limited role in the suppression of myofibrillar
protein degradation by Lys (Sato et al. 2014), and it has
been shown that Leu also regulates the autophagic-
lysosomal system in an mTOR-independent manner
(Mordier et al. 2000). Furthermore, Zhao et al. (2007)
have shown that Akt, rather than mTOR, is a master
regulator of autophagy in myotubes. Therefore, it is
likely that the activation of Akt plays a primary role in
the regulation of autophagic-lysosomal activity by Lys.
In this study, we observed that Leu also regulates some
signals in similar manner to Lys. From these results, the
regulatory mechanism on autophagy by Lys may be simi-
lar to that by Leu. However, the stimulatory effect of Leu
on mTOR signaling was significantly higher than that of
Lys in this study (Figure 5c) and previous study (Sato
et al. 2014). Therefore, the regulation of mTOR signaling
or protein synthesis by Lys may be weaker than that by
Leu. Further study is needed to clarify that similarity
and difference between Leu and Lys signals on regula-
tion of protein metabolism.
Figure 7 Effect of Lys and/or AICAR on gene expression of MuRF1 and atrogin-1 mRNA in C2C12 myotubes. Cells were treated with
DMSO (C), 1 mM AICAR (Ac), 10 mM Lys (K), or 10 mM Lys and 1 mM AICAR (AcK) for 30 min (filled bar) or 4 h (open bar). The expression of
MuRF1 (a) and atrogin-1 (b) mRNA was analyzed as described in “Materials and Methods”. Results are shown as expression relative to the control
group. Values are means with SE (n = 3). Different letters indicate significant differences among the groups at the same time point (p < 0.05).
Sato et al. SpringerPlus 2014, 3:584 Page 9 of 12
http://www.springerplus.com/content/3/1/584AMPK is also a regulator of autophagy (Sanchez et al.
2012). Leu has been reported to regulate protein turn-
over by suppressing AMPK (Du et al. 2007; Wilson et al.
2011). In this study, we showed that Lys suppresses
AMPK phosphorylation, and that the suppressive effect
of Lys on AMPK phosphorylation was completely abol-
ished when Akt activity was inhibited (Figure 4b). Leu
similarly regulated AMPK phosphorylation by Akt in
C2C12 cells. AMPK is a downstream target of Akt
(Kovacic et al. 2003; Horman et al. 2006; Bertrand et al.
2008; Suzuki et al. 2013). Therefore, the current results
indicate that both Lys and Leu suppress AMPK phos-
phorylation through Akt activation in C2C12 cells.C2C12 myotubes were treated with AICAR for 4 h to
examine the involvement of AMPK activity in the deg-
radation of myofibrillar protein. Treatment with AICAR
alone had essentially no effect on MeHis release from
cells (Figure 6). In contrast, Nakashima and Yakabe
(2007) showed that activation of AMPK by AICAR stim-
ulates myofibrillar protein degradation in C2C12 cells.
This discrepancy between the two sets of results may be
due to the different treatment times (24 h in the study
by Nakashima and Yakabe, and 4 h in this study); alter-
natively, AMPK activity might have been sufficiently
high in the current study to promote the degradation of
myofibrillar protein even under basal conditions without
Figure 8 Comparison of Lys and Gly stimulation on the phosphorylation of Akt and AMPK, and on the activity of the autophagic-lysosomal
system in C2C12 myotubes. Cells were untreated (C) or treated with 10 mM Lys (K) or 10 mM Gly (G) for 30 min. The phosphorylation levels of Ser473
in Akt (a), Thr308 in Akt (b), AMPK (c), and the ratio of LC3-II to total LC3 (LC3-I + LC3-II) (d), were determined in the lysates by Western blotting. Results
are expressed as the level relative to that of the control group. Values are means with SE (n = 3–4). Different letters indicate significant differences among
the groups (p < 0.05).
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the presence of AICAR, the ratio of LC3-II to total LC3
remained suppressed, and Lys did not affect the activa-
tion of AMPK by AICAR (Figure 5a and d). These re-
sults suggested that autophagic-lysosomal activity might
be dominantly regulated by Akt rather than AMPK
pathway in this study. Furthermore, the rate of myofi-
brillar protein degradation significantly increased in
C2C12 cells treated with Lys and AICAR (AcK) compared
to cells treated with Lys alone (K) (Figure 6). To investi-
gate why myofibrillar protein degradation increased upon
treatment with Lys and AICAR, we assessed the activity ofthe major proteolytic system, the ubiquitin-proteasomal
system. The mRNA levels of MuRF1 and atrogin-1 were
significantly increased in C2C12 cells 30 min and 4 h
following the addition of Lys and AICAR (AcK) com-
pared to the other groups (C, Ac, K) (Figure 7).
Therefore, the activation of AMPK in the presence of some
amino acids may stimulate the ubiquitin-proteasomal
system and increase the rate of myofibrillar protein
degradation in C2C12 cells, although the mechanism
of this phenomenon is unclear.
On the other hand, AMPK has been shown to regulate
protein synthesis through the mTOR pathway in C2C12
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When AMPK was phosphorylated by AICAR, mTOR
signaling activity was significantly suppressed compared
to in the presence of Lys alone (Figure 5c). This result
indicates that the suppressive effect of Lys on AMPK
phosphorylation may help up-regulate protein synthesis
by activating the mTOR pathway, rather than by regulating
autophagic activity.
The nutritional value of Lys has been well-appreciated
because Lys is a major limiting essential amino acid in
some plant proteins, such as wheat gluten. Addition of
Lys to low-Lys diet has been reported to help animal
growth whereas animals which fed a low-Lys diet grow
more slowly than those fed a diet containing adequate
amounts of Lys (Nagao et al. 2010; Ishida et al. 2011).
However, there is little information of molecular mecha-
nisms in the health-promoting benefits of Lys until now.
In this study, we indicated that Lys may act as regulator
of autophagy and some signal molecules which control
protein turnover in C2C12 cells. The current results
may provide basis for the development of nutritional
treatment for muscle wasting and muscle mass gain by
daily diet, and may contribute to the understanding the
physiological function of amino acids and its molecular
mechanism in skeletal muscle cells.
In conclusion, this study demonstrated for the first
time that Lys suppresses myofibrillar protein degrad-
ation by regulating the autophagic-lysosomal system
through phosphorylation of Akt. Consequently, Lys is an
important regulatory amino acid in protein metabolism
and exerts its effect via the Akt pathway.Abbreviations
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